BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16959056)

  • 1. Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors.
    Nonogaki K; Nozue K; Takahashi Y; Yamashita N; Hiraoka S; Kumano H; Kuboki T; Oka Y
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):675-81. PubMed ID: 16959056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine exerts anorexic effect in 5-HT2C receptor mutant mice with heterozygous mutation of beta-endorphin gene.
    Nonogaki K; Ohba Y; Wakameda M; Tamari T
    Int J Neuropsychopharmacol; 2009 May; 12(4):547-52. PubMed ID: 18976545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic orexin and pro-opiomelanocortin activities are essential for the anorexic effects of m-chlorophenylpiperazine in mice.
    Nonogaki K; Kaji T
    Int J Neuropsychopharmacol; 2010 Oct; 13(9):1261-7. PubMed ID: 20587130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperphagia alters expression of hypothalamic 5-HT2C and 5-HT1B receptor genes and plasma des-acyl ghrelin levels in Ay mice.
    Nonogaki K; Nozue K; Oka Y
    Endocrinology; 2006 Dec; 147(12):5893-900. PubMed ID: 16973729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milnacipran, a serotonin and norepinephrine reuptake inhibitor, induces appetite-suppressing effects without inducing hypothalamic stress responses in mice.
    Nonogaki K; Nozue K; Kuboki T; Oka Y
    Am J Physiol Regul Integr Comp Physiol; 2007 May; 292(5):R1775-81. PubMed ID: 17218444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.
    Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
    Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice.
    Lee MD; Somerville EM; Kennett GA; Dourish CT; Clifton PG
    Psychopharmacology (Berl); 2004 Oct; 176(1):39-49. PubMed ID: 15138762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
    Yamauchi M; Tatebayashi T; Nagase K; Kojima M; Imanishi T
    Pharmacol Biochem Behav; 2004 Aug; 78(4):683-9. PubMed ID: 15301922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social instigation and aggressive behavior in mice: role of 5-HT1A and 5-HT1B receptors in the prefrontal cortex.
    Centenaro LA; Vieira K; Zimmermann N; Miczek KA; Lucion AB; de Almeida RM
    Psychopharmacology (Berl); 2008 Dec; 201(2):237-48. PubMed ID: 18688602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex.
    de Groote L; Klompmakers AA; Olivier B; Westenberg HG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):89-94. PubMed ID: 12595948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors.
    Lam DD; Przydzial MJ; Ridley SH; Yeo GS; Rochford JJ; O'Rahilly S; Heisler LK
    Endocrinology; 2008 Mar; 149(3):1323-8. PubMed ID: 18039773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice.
    Nonogaki K; Ohashi-Nozue K; Oka Y
    Biochem Biophys Res Commun; 2006 Mar; 341(3):703-7. PubMed ID: 16430857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
    McMahon LR; Cunningham KA
    Neuropsychopharmacology; 2001 Mar; 24(3):319-29. PubMed ID: 11166521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221.
    Conductier G; Crosson C; Hen R; Bockaert J; Compan V
    Neuropsychopharmacology; 2005 Jun; 30(6):1056-63. PubMed ID: 15668722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice.
    Nonogaki K; Ohba Y; Sumii M; Oka Y
    Biochem Biophys Res Commun; 2008 Jul; 372(1):186-90. PubMed ID: 18477467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin 5-HT2C receptor-mediated inhibition of the M-current in hypothalamic POMC neurons.
    Roepke TA; Smith AW; Rønnekleiv OK; Kelly MJ
    Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1399-406. PubMed ID: 22436698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.
    Fabre V; Beaufour C; Evrard A; Rioux A; Hanoun N; Lesch KP; Murphy DL; Lanfumey L; Hamon M; Martres MP
    Eur J Neurosci; 2000 Jul; 12(7):2299-310. PubMed ID: 10947809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.